4569 — Kyorin Pharmaceutical Share News
0.000.00%
Last trade - 00:00- ¥65bn
- ¥71bn
- ¥126bn
Brief: Kyorin Holdings to repurchase up to 24.1 pct shares for 44.35 bln yen
Brief: Kyorin Receives Japanese Regulatory Approval For Vibegron For Overactive Bladder
Brief: Kissei Pharmaceutical says marketing approval for "Beova® Tablets 50mg" for treatment of overactive bladder
Table: Kyorin Holdings -Q1 group results
Brief: Kyorin Holdings unit and FAES Farma sign agreement on development and distribution of Imidafenacin in Latin America
Table: Kyorin Holdings -Q1 group results
Table: Kyorin Holdings -2017/18 parent results
Table: Kyorin Holdings -2017/18 group results
Brief: Suzuken unit signs license agreement regarding SK-1404 for treatment of frequent urination at night
Brief: R&I affirms Kyorin Holdings rating at "A-" and says stable outlook -R&I
Table: Kyorin Holdings - 9-MTH group results
Brief: Kyorin Holdings says integration of production function
Brief: Kyorin Holdings unit signs production and marketing license agreement with vietnamese pharmaceutical company
Table: Kyorin Holdings - 6-MTH group results
Table: Kyorin Holdings Inc -2017 6-month group forecast
Brief: Kyorin Holdings to set up drug unit in Tokyo
Table: Kyorin Holdings -Q1 group results
Brief: Kyorin Holdings unit Kyorin Pharmaceutical to buy jTAS
Brief: Kyorin Holdings to integrate production function